A muscle-physiology researcher at Aarhus University who discovered that the ClC-1 muscle chloride channel could be targeted to restore neuromuscular transmission, then spun out NMD Pharma in 2015 to turn that science into treatments, serving as CEO.
Studied at
Aarhus University (PhD Physiology)University of Cambridge (postdoctoral research)
Before
Researcher in muscle physiology at Aarhus University